In vitro diagnostics markets rely on outsourcing to complete products needed to fulfill the demand for clinical tests. This report, Contract Manufacturing in IVD: Market Analysis, looks at this industry. The report provides market projections and examines the companies that build IVD devices, reagents, antibodies, and other accessories for major IVD companies.
For each major market segment, the report breaks out the contracting market for IVD products, including market sizing and regional trends for 2017 with forecasts to 2022 for the following:
Global Contract IVD Manufacturing Demand by Technology, 2017-2022
Global Contract IVD Manufacturing Demand by Country/Region, 2017-2022
Global Contract IVD Manufacturing Demand by Product Group, 2017-2022
Global Contract Point of Care (POC) IVD Product Demand by Type,
- Global Contract Immunoassay Product Demand by Type
- Global Contract Clinical Chemistry Product Demand by Type
Global Contract Microbiology IVD Product Demand by Type
Global Contract Molecular Diagnostics Demand by Type
Global Contract Hematology IVD Product Demand by Type, 2017-2022
Global Histology/Cytology IVD Product Demand by Type
Global Contract Coagulation IVD Product Demand by Type
- Global Contract Blood Grouping IVD Product Demand by Type
- Affinity Biologicals, Inc.
- Antibodies Incorporated
- Biokit S.A.
- BIT Group
- Cenogenics Corporation
- Collagen Solutions plc
- Coris Bioconcept
- Custom Diagnostics
- DiaCarta Inc.
- EKF Diagnostic Holdings plc
- Guilin Royalyze Medical Co. Ltd.
- KMC Systems Inc.
- Maxim Biomedical Inc.
- Meridian Life Science Inc.
- Polymed Therapeutics, Inc.
- Promega Corporation
- Savyon Diagnostics
- Sekisui Diagnostics LLC
Key Topics Covered:
1. Executive Summary
2. Market Environment
3. IVD Products
4. Contract IVD Manufacturing
5. Industry Structure
For more information about this report visit https://www.researchandmarkets.com/research/b4452s/contract?w=4